Use of CAR-T treatments and their efficacy in Prostate Cancer
We already know that Immunotherapies have not performed well in the treatment of prostate cancer. Such medicines have failed to elicit a long-term response in patients with advanced prostate cancer. Surgery, radiation treatment, chemotherapy, androgen deprivation therapy (ADT), new anti-androgen medicines and androgen synthesis inhibitors, including PARP inhibitors are currently used to treat prostate cancer. Radiopharmaceutical agents for the treatment of prostate cancer are about to enter the major markets. Mutation-specific therapies are also being investigated for the treatment of prostate cancer. In...
